Diabetes MellitusJohn A. Galloway, Janet H. Potvin, Charles R. Shuman Lilly Research Laboratories, 1988 - 335 pages |
From inside the book
Results 1-3 of 45
Page 60
... Glucagon Deficiency E Glucagon Deficiency plus a / B Blockage 60 Time ( minutes ) Plasma glucose curves during insulin - induced hypoglycemia in normal subjects during control studies ( solid lines ) and as modified ( dashed lines ) by ...
... Glucagon Deficiency E Glucagon Deficiency plus a / B Blockage 60 Time ( minutes ) Plasma glucose curves during insulin - induced hypoglycemia in normal subjects during control studies ( solid lines ) and as modified ( dashed lines ) by ...
Page 63
... glucagon secretion and in insulin receptor binding in diabetes mellitus . J Clin Endocrinol Metab 1979 ; 48 : 999 ... Glucagon and gluconeo- genesis , in Lefebvre P ( ed ) : Glucagon I. New York , Springer - Verlag , 1983 , p 315 . 42 ...
... glucagon secretion and in insulin receptor binding in diabetes mellitus . J Clin Endocrinol Metab 1979 ; 48 : 999 ... Glucagon and gluconeo- genesis , in Lefebvre P ( ed ) : Glucagon I. New York , Springer - Verlag , 1983 , p 315 . 42 ...
Page 259
... glucagon intra- muscularly or intravenously . " Intramuscularly or intravenously administered glucagon must be followed by oral carbohydrate . glucose ( dextrose ) solution intravenously . If inef- fective , a second intravenous push ...
... glucagon intra- muscularly or intravenously . " Intramuscularly or intravenously administered glucagon must be followed by oral carbohydrate . glucose ( dextrose ) solution intravenously . If inef- fective , a second intravenous push ...
Contents
Definition | 1 |
Chapter 2 iabetes Mellitus and Heredity | 15 |
Chapter 3 athophysiology of Diabetes Mellitus | 27 |
Copyright | |
15 other sections not shown
Common terms and phrases
abnormalities action activity agents antibodies associated betes blood glucose blood glucose concentrations body carbohydrate cause cells changes Chapter clinical complications continuous daily decrease determinations diabetes mellitus diabetic diet diabetic ketoacidosis diagnosis diet disease dose early effect exercise factors Figure given glucose tolerance glycemic glycosylated hemoglobin hormone human insulin hypoglycemia impaired important improved increased indicated individuals initial injection insulin infusion insulin receptor insulin resistance insulin secretion insulin therapy insulin-dependent levels lipoprotein liver meals measure metabolic methods mg/dl mmol/L monitoring muscle myocardial infarction needed normal obese occur oral patients with diabetes patients with Type plasma glucose pregnancy prevent production protein pump receptor reduced regular renal reported response retinopathy risk severe Source studies subcutaneous subjects Table therapy tion tissue treated treatment Type I diabetes Type II units urine usually values weight